A Trusted Supplier of Life Science Tools
Repligen's Bioprocessing Business

For over 20 years, Repligen has also made a difference in patients' lives through its commitment to quality in its bioprocessing business. Through the sale of its Protein A products, Repligen provides the biopharmaceutical industry with tools used in the manufacturing of therapeutic and diagnostic monoclonal antibodies. Monoclonal antibodies are the largest class of biological drugs and include important new therapies for rheumatoid arthritis and cancer, and the class continues to grow. Sales of Repligen's recombinant Protein A products have resulted in a steady revenue stream for the company, allowing Repligen to continue to invest in its bioprocessing product line in order to capture this growing market, while at the same time funding development of its therapeutic pipeline.

Learn more about Repligen's Bioprocessing Business.